Disease-associated hepatocytes are predictive of outcomes and survival in MASLD beyond fibrosis staging

Gut. 2025 Sep 10:gutjnl-2025-336627. doi: 10.1136/gutjnl-2025-336627. Online ahead of print.
No abstract available

Keywords: BIOMARKERS; CIRRHOSIS; FATTY LIVER; HEPATOCELLULAR CARCINOMA; HEPATOCYTE.

Publication types

  • Letter